MediWound Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on March 30, 2026, by MediWound Ltd., a foreign private issuer based in Yavne, Israel, serves to distribute proxy materials for the Company's 2026 Annual General Meeting of Shareholders. The meeting is scheduled to be held on May 6, 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly for the purpose of notifying shareholders of the upcoming annual meeting and distributing related proxy documents.
Material Changes
No material financial changes or operational updates are disclosed in this specific filing. The document focuses solely on corporate governance procedures regarding the shareholder meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It incorporates by reference the Notice of the 2026 Annual General Meeting and Proxy Statement (Exhibit 99.1) and the Proxy Card (Exhibit 99.2), which may contain further details on matters to be voted upon.
Key Facts for Investors
- Meeting Date: The 2026 Annual General Meeting is scheduled for May 6, 2026.
- Document Purpose: This filing distributes the Notice of Meeting, Proxy Statement, and Proxy Card to shareholders.
- Financial Data: No financial results or metrics are included in this specific Form 6-K.
- Signatory: The report was signed by Hani Luxenburg, Chief Financial Officer, on March 30, 2026.